Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Triple Negative Breast Neoplasms × selinexor × 90 days × Clear all

Sponsor

Conditions

Multiple Myeloma 13 Recurrence 4 Sarcoma 2 Glioblastoma 2 Vascular Neoplasms 1 Solitary Fibrous Tumors 1 Smooth Muscle Tumor 1 Sarcoma, Clear Cell 1 Sarcoma, Alveolar Soft Part 1 Salivary Gland Neoplasms 1 Primary Myelofibrosis 1 Osteosarcoma 1 Neurofibrosarcoma 1 Nerve Sheath Neoplasms 1 Neoplasms, Adipose Tissue 1 Neoplasms 1 Neoplasm Metastasis 1 Myoepithelioma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Liposarcoma, Myxoid 1 Liposarcoma 1 Leukemia, Myeloid, Acute 1 Leukemia, Biphenotypic, Acute 1 Hodgkin Disease 1 Histiocytoma, Angiomatoid Fibrous 1 Hemangiosarcoma 1 Hemangioendothelioma, Epithelioid 1 Granuloma, Plasma Cell 1

Interventions

pembrolizumab 41 Carboplatin 22 Paclitaxel 21 Specimen Handling 16 Biopsy 14 Magnetic Resonance Spectroscopy 13 Cyclophosphamide 12 Capecitabine 10 130-nm albumin-bound paclitaxel 9 olaparib 8 Doxorubicin 8 Albumin-Bound Paclitaxel 8 Gemcitabine 7 eribulin 6 sacituzumab govitecan 5 Taxes 5 Bevacizumab 5 toripalimab 4 atezolizumab 4 Standard of Care 4 Nivolumab 4 Injections 4 Drug Therapy 4 Docetaxel 4 liposomal doxorubicin 3 durvalumab 3 capivasertib 3 X-Rays 3 Radiation 3 Platinum 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡